NCT01473641View on ClinicalTrials.gov

Nexplanon Observational Risk Assessment Study (NORA)

CompletedOBSERVATIONAL
Enrollment

7,364

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Contraception
Trial Locations (1)

Unknown

Center for Epidemiology and Health Research, Berlin

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Center for Epidemiology and Health Research, Germany

OTHER

NCT01473641 - Nexplanon Observational Risk Assessment Study (NORA) | Biotech Hunter | Biotech Hunter